DHR logo Danaher Corporation +
Danaher Corporation
+

Danaher Corporation (DHR) Business News

Track Danaher Corporation in real time with a live news feed covering Danaher Corporation stock news, official press releases, company announcements, and an archive of historical Danaher Corporation news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection

Danaher: 2027 Growth Reacceleration Should Drive Upside

Seeking Alpha

3:26 PM | Friday | Aug 14, 2026

news photo
Loading...

Danaher is rated a Buy, with revenue growth expected to accelerate in 2027 as respiratory headwinds fade and bioprocessing shipments recover. DHR's valuation is reasonable, trading at a 12% discount to its five-year average P/E, supported by strong recurring revenues and operational excellence. Life Sciences segment shows robust recovery, with 5.5% core growth and margin expansion, driven by improved pharma spending and biotech funding.

Read full article redirect
3:26 PM | Friday | Aug 14, 2026

Danaher: 2027 Growth Reacceleration Should Drive Upside

Seeking Alpha

Danaher is rated a Buy, with revenue growth expected to accelerate in 2027 as respiratory headwinds fade and bioprocessing shipments recover. DHR's valuation is reasonable, trading at a 12% discount to its five-year average P/E, supported by strong recurring revenues and operational excellence. Life Sciences segment shows robust recovery, with 5.5% core growth and margin expansion, driven by improved pharma spending and biotech funding.

Read full article arrow
News Thumbnail
3:26 PM | Friday | Aug 14, 2026

Danaher: 2027 Growth Reacceleration Should Drive Upside

Seeking Alpha

Danaher is rated a Buy, with revenue growth expected to accelerate in 2027 as respiratory headwinds fade and bioprocessing shipments recover. DHR's valuation is reasonable, trading at a 12% discount to its five-year average P/E, supported by strong recurring revenues and operational excellence. Life Sciences segment shows robust recovery, with 5.5% core growth and margin expansion, driven by improved pharma spending and biotech funding.

Read full article arrow
News Thumbnail
9:10 PM | Thursday | Aug 6, 2026

Diamond Hill Small-Mid Cap Fund Q2 2026 Portfolio Review

Seeking Alpha

The Fund increased 9.71% compared to a 20.26% increase for the Russell 2500 Index. We initiated a position in managed care provider Centene. Shares of website design software provider Wix.
com were sold as the company's core business has experienced slowing growth due to AI-driven vibe coding.

Read full article arrow
News Thumbnail
4:15 PM | Monday | Aug 3, 2026

Danaher Appoints Julie Sawyer Montgomery as President and Chief Executive Officer

PRNewsWire

Rainer Blair to retire WASHINGTON, Aug. 3, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") announced that the Company's Board of Directors has appointed Julie Sawyer Montgomery as President and Chief Executive Officer and a member of the Board of Directors, effective October 1, 2026. On that date, Rainer Blair will retire and serve as a senior advisor until March 31, 2027 to ensure a seamless transition.

Read full article arrow
News Thumbnail
3:55 AM | Saturday | Aug 1, 2026

Danaher Corporation $DHR Shares Sold by Argent Capital Management LLC

Defense World

Argent Capital Management LLC trimmed its position in Danaher Corporation (NYSE: DHR) by 8.6% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 322,260 shares of the conglomerate's stock after selling 30,439 shares during the quarter. Danaher comprises 1.9% of Argent Capital

Read full article arrow
News Thumbnail
1:20 AM | Thursday | Jul 30, 2026

Aristotle Global Equity Advisory Q2 2026 Portfolio Review

Seeking Alpha

For the second quarter of 2026, Aristotle Capital's Global Equity WM Composite posted a total return of 6.92% pure gross of fees (6.40% net of fees), underperforming the MSCI ACWI Index, which returned 14.93%, and the MSCI World Index, which returned 13.76%.
During the quarter, we sold our positions in Danaher, Dolby Laboratories, and Tokyo Century and purchased Techtronic Industries and Wal-Mart de Mexico. Munich Re, the world's largest reinsurance company, was a detractor during the quarter.

Read full article arrow
News Thumbnail
3:45 AM | Wednesday | Jul 29, 2026

Danaher Corporation $DHR Stock Holdings Increased by ADAR1 Capital Management LLC

Defense World

ADAR1 Capital Management LLC grew its holdings in shares of Danaher Corporation (NYSE: DHR) by 20.8% in the first quarter, according to its most recent filing with the SEC. The firm owned 30,932 shares of the conglomerate's stock after acquiring an additional 5,332 shares during the quarter. ADAR1 Capital Management LLC's holdings in

Read full article arrow
News Thumbnail
4:24 AM | Monday | Jul 27, 2026

Caxton Associates LLP Takes Position in Danaher Corporation $DHR

Defense World

Caxton Associates LLP bought a new stake in Danaher Corporation (NYSE: DHR) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 5,612 shares of the conglomerate's stock, valued at approximately $1,064,000. Other institutional investors and hedge funds have also recently bought and sold

Read full article arrow
News Thumbnail
4:09 AM | Saturday | Jul 25, 2026

Bank of Nova Scotia Sells 3,275 Shares of Danaher Corporation $DHR

Defense World

Bank of Nova Scotia lessened its stake in shares of Danaher Corporation (NYSE: DHR) by 1.6% in the undefined quarter, according to its most recent disclosure with the SEC. The firm owned 202,353 shares of the conglomerate's stock after selling 3,275 shares during the period. Bank of Nova Scotia's holdings in Danaher were

Read full article arrow
News Thumbnail
10:13 AM | Friday | Jul 24, 2026

Here's Why the Slump in Danaher Stock This Week Looks Like a Buying Opportunity

Fool - Investing News

The company delivered a mixed earnings report, but the sell-off looks like an overreaction.

Read full article arrow
News Thumbnail
10:56 AM | Wednesday | Jul 22, 2026

Can Danaher (DHR) Climb 32.39% to Reach the Level Wall Street Analysts Expect?

Zacks Investment Research

The average of price targets set by Wall Street analysts indicates a potential upside of 32.4% in Danaher (DHR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Read full article arrow
News Thumbnail